Franklin Resources’s Trevi Therapeutics TRVI Stock Holding History

Franklin Resources’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$932K	Buy	49,966 +88	+0.2%	+$1.28K	﹤0.01%	2308
2026 Q1	$595K	Hold	49,878	–	–	﹤0.01%	2403
2025 Q4	$624K	Hold	49,878	–	–	﹤0.01%	2302
2025 Q3	$456K	Sell	49,878 -40	-0.1%	-$300	﹤0.01%	2468
2025 Q2	$273K	Buy	49,918 +12,647	+34%	+$78.7K	﹤0.01%	2600
2025 Q1	$234K	Buy	+37,271	New	+$178K	﹤0.01%	2606
2020 Q2	–	Sell	-587,347	Closed	-$1.93M	–	1738
2020 Q1	$1.93M	Hold	587,347	–	–	﹤0.01%	1098
2019 Q4	$2.2M	Sell	587,347 -112,653	-16%	-$422K	﹤0.01%	1155
2019 Q3	$3.15M	Hold	700,000	–	–	﹤0.01%	1086
2019 Q2	$5.25M	Buy	+700,000	New	+$6.03M	﹤0.01%	1015

Other funds holding TRVI

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Franklin Resources's TRVI Position: Q2 2026 in Review

Franklin Resources increased its Trevi Therapeutics (TRVI) stake by 0.18% in Q2 2026, buying an estimated $1.28K and bringing the position to 49,966 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Franklin Resources first reported a position in TRVI in Q2 2019 and has held it in 10 quarters since. The position peaked at $5.25M in Q2 2019. 219 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

Franklin Resources held 49,966 shares of Trevi Therapeutics worth $932K as of Q2 2026.
Franklin Resources bought 88 Trevi Therapeutics shares in Q2 2026, an estimated $1.28K.
Trevi Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2308 holding.
Franklin Resources first reported a position in Trevi Therapeutics in Q2 2019 and has held it in 10 quarters since.
Franklin Resources's Trevi Therapeutics position peaked at $5.25M in Q2 2019.
219 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.